3 among others 10 ] to afford these compounds have been reported in literature. In this sense, Lipshutz described the aerobic oxosulfonylation of arylacetylenes within nanomicelles in water [eqn (i)]. 11 During one of our ongoing research projects, focused on the development of novel triazolic antifungal compounds from ketones (e.g. β-Ketosulfones) 12 as starting materials, we synthetized compounds S1b-S10b from S1a-S10a according to previously described methodologies [Scheme SI-1, eqn (a)-(h)]. The desired products were obtained with high temperatures, but it is of utmost importance to employ a very mild and eco-friendly method for the synthesis of β-ketosulfones. Therefore, we tried to obtain compound S1b from α-bromo ketone S1a in water at room temperature without any co-organic solvent. Unfortunately, no reaction was observed within 120 h. Evidently, the insolubility of the starting material S1a prevents its interaction with the metal sulfinate salt (highly soluble in water).
Surprisingly, when the substrates were subjected to a catalytic aqueous solution of SPGS-550-M at room temperature, the corresponding β-Ketosulfone S1b was attained in a very clean reaction in TLC, isolated in high yields (91%). Scheme SI-1. Lipshutz's work opened the door to improving the attainment of β-ketosulfones through eco-friendly methods.
These results led us to investigate the alkylation of the α-halo ketone S1a with aryl sulfinate salt in greater detail.
Firstly, an excess (1.5 eq) of sodium p-toluenesulfinate (p-TolSO 2 Na) was necessary to allow for a complete reaction. Secondly, TLC provided a complete reaction after 12 h. Despite the similar yields obtained when using a hermetic (89%) versus open-flask (91%) system, we decided to adopt the latter as the standard. To evaluate the scope of our protocol, both arylic (S2a-S6a, S11a and S12a) and heteroarylic (S7a-S10a) α-bromo ketone derivatives 13 were subjected to the optimized reaction conditions (Table SI-1) . In general, primary bromo alkyl substrates showed excellent yields (71-92%). Unfortunately, both secondary bromo S11a and chloroalkyl S12a derivatives remained intact in the solution. 
S10a S10b (84%) 10 S11a S11b (trace) c 11 S12a S12b (trace) c a Reaction conditions: A mixture of 1 mmol of α-bromo ketone and 1.5 mmol of pTol-SO 2 Na in 3 mL of SPGS-550-M aq. (2% w/w) was stirred at r. t. for 12 h in an 'open-flask' system. b Yields refer to chromatographically pure isolated compounds. c These experiments were carried out at 100 °C as well.
In conclusion, we have developed a novel organic solvent-free synthesis of β-ketosulfones with aqueous nanomicellar medium. The surfactant nature of SPGS-550-M or 'NOK' (a third generation surfactant) allows it to act as an efficient nanoreactor in catalytic amounts. The notable advantages of this methodology over those previously reported include its simplicity of handling, mild conditions, high yields, cheap reagents and great tolerance of functional groups.
General experimental procedure for the direct conversion of α-bromo ketones to β-ketosulfones: To a 10-mL round-bottom flask equipped with a magnetic stir bar was added 1 mmol of α-bromo ketone. and J in Hz. MS was conducted on a Shimadzu GCMS-QP2010 Plus apparatus in m/z (rel. %).
Experimental procedures

3-(2-chloroethyl)-4,5-diphenyloxazol-2(3H)-one 7
In a sealed tube 2-chloroethyl isocyanate 6 (0. 
3-(2-azidoethyl)-4,5-diphenyloxazol-2(3H)-one 8
To a mixture of the 3-(2-chloroethyl)-4,5-diphenyloxazol-2(3H)-one 7 (0.105 g, 0.6 mmol) in 3 mL of DMF was added sodium azide (0.043 g, 0.66 mmol). It was stirred for 12 hours at 60 °C under nitrogen atmosphere.
Afterwards, TLC indicated the disappearance of the starting materials, and then the solution was brought to room temperature under continuous stirring for 20 min. DMF was removed with extractions by using a brine solution and AcOEt, dried over anhydrous Na 2 SO 4 , filtered and concentrated under reduced pressure. The crude was purified by flash chromatography over silica, eluting with AcOEt /hexane 1/9 to furnish the white solid 8 (0.062 g, 58% 4,5-diphenyl-3-(2-(5-phenyl-4-tosyl-1H-1,2,3-triazol-1-yl) 
ethyl)oxazol-2(3H)-one 4a
To a solution of the azide 8 (0.045 g, 0.15 mmol) and ketone 11a (0.043 g, 0.15 mmol) dissolved in anhydrous DMF (3 mL) was added DBU (0.044 mL, 0.3 mmol) under nitrogen atmosphere. The solution was stirred for 24 h at 50-60°C, at which time TLC indicated the disappearance of the starting materials. Brine (~40 mL) was added and then the reaction mixture was washed with EtOAc (3x10 mL). The organic layer was dried (Na 2 SO 4 ) and the solvent evaporated under reduced pressure. The crude extract was purified by flash column chromatography, eluting with hexane/AcOEt 3/7 to provide the white solid 4a (0.062 g, 58% 
4,5-diphenyl-3-(2-(5-(p-tolyl)-4-tosyl-1H-1,2,3-triazol-1-yl)ethyl)oxazol-2(3H)-one 4b
Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11b (0.042 g, 0.15 mmol) were coupled in the presence of DBU (0.044 mL, 0.3 mmol). The crude extract was purified by flash column chromatography, eluting with hexane/AcOEt 3/7 to yield the brown solid 4b (0.0523 g, 61% 
3-(2-(5-(4-nitrophenyl)-4-tosyl-1H-1,2,3-triazol-1-yl)ethyl)-4,5-diphenyloxazol-2(3H)-one 4c
Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11c (0.047 g, 0.15 mmol) were coupled in the presence of DBU (0.044 mL, 0.3 mmol). The crude extract was purified by flash column chromatography, eluting with hexane/AcOEt 3/7 to give the yellow solid 4c (0.0661 g, 74% 
3-(2-(5-(3-nitrophenyl)-4-tosyl-1H-1,2,3-triazol-1-yl)ethyl)-4,5-diphenyloxazol-2(3H)-one 4d
Following the synthetic procedure for 4a, compound 8 (0. 
3-(2-(5-(4-chlorophenyl)-4-tosyl-1H-1,2,3-triazol-1-yl)ethyl)-4,5-diphenyloxazol-2(3H)-one 4e
Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11e (0.046 g, 0.15 mmol) were coupled in the presence of DBU (0.044 mL, 0.3 mmol). The crude extract was purified by flash column chromatography, eluting with hexane/AcOEt 3/7 to furnish the yellow solid 4e (0.0621 g, 72% 
4,5-diphenyl-3-(2-(5-(thiophen-2-yl)-4-tosyl-1H-1,2,3-triazol-1-yl)ethyl)oxazol-2(3H)-one 4f
Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11f (0.043 g, 0.15 mmol) were coupled in the presence of DBU (0.044 mL, 0.3 mmol). The crude extract was purified by flash column chromatography, eluting with hexane/AcOEt 3/7 to provide the yellow oil 4f (0.0593 g, 68% 
3-(2-(5-(5-chlorothiophen-2-yl)-4-tosyl-1H-1,2,3-triazol-1-yl)ethyl)-4,5-diphenyloxazol-2(3H)-one 4g
Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11g (0.047 g, 0.15 mmol) were coupled in the presence of DBU (0.044 mL, 0.3 mmol). The crude extract was purified by flash column chromatography, eluting with hexane/AcOEt 3/7 to yield the brown solid 4g (0.0575 g, 64% 
3-(2-(5-pentyl-4-tosyl-1H-1,2,3-triazol-1-yl)ethyl)-4,5-diphenyloxazol-2(3H)-one 4h
Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11h (0.038 g, 0.15 mmol) were ppm.
3-(2-(4-acetyl-5-methyl-1H-1,2,3-triazol-1-yl)ethyl)-4,5-diphenyloxazol-2(3H)-one 4i
Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11i ( 
3-(2-(4-benzoyl-5-phenyl-1H-1,2,3-triazol-1-yl)ethyl)-4,5-diphenyloxazol-2(3H)-one 4j
Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11j (0.0336 g, 0.15 mmol) were coupled in the presence of DBU (0.044 mL, 0.3 mmol). The crude extract was purified by flash column chromatography, eluting with hexane/AcOEt 3/7 to furnish the yellow solid 4j (0.0545 g, 71%). Rf: 0.11 1- (2-(2-oxo-4,5-diphenyloxazol-3(2H)-yl)ethyl)-5-phenyl-1H-1,2,3-triazole-4-carbonitrile 4k Following the synthetic procedure for 4a, compound 8 (0.045 g, 0.15 mmol) and 11k (0.0213 g, 0.15 mmol) were coupled in the presence of DBU (0.044 mL, 0.3 mmol). The crude extract was purified by flash column chromatography, eluting with hexane/AcOEt 3/7 to provide the yellow solid 4k (0.0636 g, 67% 
Microbiology
The culture medium used is synthetic medium RPMI 1640 with glutamine and without sodium bicarbonate, buffered with morpholino propane sulfonic acid (MOPS) 0.164 M adjusted to pH 7 ± 0.1 and with 0.2% glucose. The standard compound is Itraconazole.
Method M27-A3 Yeast.
A) Antifungals insoluble in water (itraconazole)
1. Prepare a solution with a concentration of 1600 μg / ml (100 times the highest concentration of antifungal to be tested) and dissolve it in dimethyl sulfoxide (DMSO). (FigureSI-1) .
Figure SI-1. Dilutions of water-insoluble antifungals.
The second step of the preparation is to make a 1:50 dilution to obtain a final concentration of 16-0.03 μg / mL. This process is shown in Figure SI -2.
Figure SI-2. Filling the plates.
B) Preparation of the inoculum.
It is prepared by touching with the culture loop 5 colonies ≥1 mm and 24 h growth on SDA plaques that are resuspended in a saline tube (0.85% NaCl). Stir well and, with the aid of a spectrophotometer (wavelength: 530 nm), adjust to a 0.5 McFarland optical density, adding the required amount of saline. This solution has an approximate concentration of 1x106 -5x106 CFU / ml. Subsequently a 1: 1000 dilution is performed with RPMI medium. This last dilution is the one used to inoculate the antifungal plaques.
C) Inoculation of plaques
They are inoculated with 100 μl of the yeast suspension from well 2 to 12. Column No.1 containing 200 μl of RPMI is used for the control of sterility of the medium. Column No.12 does not contain antifungal but must have the same solvent concentration as the antifungal wells. It is growth control.
D) Incubation of plates
The plates are incubated at 35 ° C. Those inoculated with Candida species for 48 h.
The visual reading should be done with the help of an inverted mirror. Azoles and 5-fluorocytosine: MIC is the lowest concentration of antifungal that produces an apparent reduction in yeast growth (≥50%), compared to control growth after 48 h of incubation.
Method M38-A. Filamentous fungi.
The characteristics of the culture medium, pH, preparation of the antifungal stock solution and dilutions are the same as those of the M27-A3 method. So far by this method the species of the genus Aspergillus, Fusarium, Rhizopus, as well as in Pseudallescheria boydii and in the micellar forms of Sporothrix schenckii have been evaluated.
In the genus Aspergillus and P. boydii species, R. arrhizus and S. schenckii the inoculum is prepared from a 7 day growth culture at 35 ° C on potato glucose agar (PDA), a medium that induces formation of conidia or Determination of the sensitivity of yeast (according to document M27-A3): Susceptible (S), dose-dependent sensitive (SDD) and resistant (R). Compound C. alb C. trop C. uti C. kru C. gla C. par 4a 
